Health Secretary Robert F. Kennedy Jr. has once again become the center of public debate following controversial remarks made during a recent high-level meeting with former President Donald Trump and other Cabinet officials. The discussion reportedly touched on public health issues, but quickly shifted when Kennedy revisited one of his most widely criticized claims: a supposed link between the common painkiller acetaminophen (often sold under the brand name Tylenol) and autism.
Despite acknowledging that no definitive medical proof exists, he reiterated his belief that further investigation is needed, reigniting an already heated controversy. This is not the first time such claims have surfaced. In earlier public appearances, Kennedy and Trump had both suggested that the use of certain medications during pregnancy could be associated with developmental conditions such as autism. However, these statements have been repeatedly challenged by medical experts and scientific organizations worldwide.
Major health authorities, including pediatric and public health institutions, have consistently stated that there is no established causal link between acetaminophen use during pregnancy and autism spectrum disorder. While research continues into the complex causes of autism, the scientific consensus remains that no single environmental factor has been proven to directly cause it.
Read more by clicking the (NEXT »») button below!
